Smiths Group (SMGZY) AI Stock Analysis

• Market Cap: $10.26B
• Dividend Yield: 1.18%
• Average Volume (3M): 1.17K
• Price to Earnings (P/E): 27.8
• Beta (1Y): 0.64
• Revenue Growth: 8.47%
• EPS Growth: 36.10%
• Country: US
• Employees: 15,750
• Sector: Industrials
• Sector Strength: 90
• Industry: Industrial - Machinery
• EPS (TTM): 0.72
• Shares Outstanding: 330,660,100
• 10 Day Avg. Volume: 2,781
• 30 Day Avg. Volume: 1,165
• PEG Ratio: 1.09
• Price to Book (P/B): 3.48
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 20.01
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: $33.00
• Price Target Upside: 4.46% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 70 Outperform
• Price Target: $33.00 ▲(4.46%Upside)

Smiths Group's stock score is primarily driven by its strong financial performance, which reflects consistent growth and effective cash management. The technical analysis indicates bullish momentum, although the overbought signals suggest caution. The valuation component suggests the stock may be overvalued, slightly tempering the overall score.

Smiths Group Business Overview & Revenue Model

Company Description

Smiths Group plc is a leading global technology company that specializes in the design, manufacture, and delivery of products and services for the medical, security, and industrial sectors. With a diverse portfolio, the company operates through its five main divisions: John Crane, Smiths Detection, Flex-Tek, Smiths Interconnect, and Smiths Medical. These divisions offer a range of products including seals and filtration systems, detection and screening solutions, engineered components for heating and fluid management, electronic components for data and signal transmission, and medical devices for healthcare applications.

How the Company Makes Money

Smiths Group generates revenue through the sale of its diverse range of products and services across its five main divisions. Each division contributes to the company's income through the manufacturing and sale of specialized products. John Crane provides mechanical seals and filtration systems primarily for the energy and petrochemical sectors. Smiths Detection offers security solutions, including detection and screening technologies for airports, ports, and borders. Flex-Tek delivers engineered components such as flexible hoses and thermal systems for various industries. Smiths Interconnect supplies advanced electronic components for data and signal transmission, catering to sectors like aerospace, defense, and telecommunications. Smiths Medical focuses on medical devices and consumables that support healthcare delivery. The company also earns from aftermarket services, including maintenance and support, which are critical in sectors like energy and security. Strategic partnerships and long-term contracts with government entities and major corporations further bolster its revenue streams.

Smiths Group Financial Statement Overview

Summary

Smiths Group presents a strong financial profile with consistent revenue growth, stable profitability, and effective cash flow management. The balance sheet shows a good balance between debt and equity, indicating a robust financial health.

Income Statement

Smiths Group has shown consistent growth in revenue and profitability. The gross profit margin is strong, reflecting efficient cost management. The net profit margin has improved steadily, indicating increased profitability. The revenue growth rate is healthy, and both EBIT and EBITDA margins are stable, indicating operational efficiency.

Balance Sheet

The balance sheet is solid with a reasonable debt-to-equity ratio, suggesting manageable leverage. The return on equity is satisfactory, indicating effective use of equity to generate profits. The equity ratio is strong, reflecting a stable financial position with a good proportion of equity financing.

Cash Flow

The company's cash flow is robust, with a steady increase in free cash flow, indicating strong cash generation capabilities. The operating cash flow to net income ratio is healthy, suggesting efficient cash generation from operations. The free cash flow to net income ratio is favorable, highlighting effective cash management.

Breakdown	Sep 2024	Sep 2023	Sep 2022	Sep 2021	Sep 2020
Income Statement
Total Revenue	3.13B	3.04B	2.57B	2.41B	2.55B
Gross Profit	1.17B	1.12B	961.00M	915.00M	989.00M
EBITDA	580.00M	580.00M	287.00M	430.00M	337.00M
Net Income	250.00M	231.00M	13.00M	157.00M	67.00M
Balance Sheet
Total Assets	4.23B	4.36B	5.22B	5.34B	5.41B
Cash, Cash Equivalents and Short-Term Investments	459.00M	285.00M	1.06B	405.00M	366.00M
Total Debt	659.00M	654.00M	1.17B	1.50B	1.56B
Total Liabilities	1.98B	1.95B	2.50B	2.91B	3.02B
Stockholders Equity	2.23B	2.38B	2.70B	2.40B	2.37B
Cash Flow
Free Cash Flow	332.00M	212.00M	191.00M	418.00M	319.00M
Operating Cash Flow	418.00M	293.00M	279.00M	535.00M	429.00M
Investing Cash Flow	39.00M	-108.00M	1.25B	-205.00M	-144.00M
Financing Cash Flow	-269.00M	-945.00M	-985.00M	-239.00M	-188.00M

Smiths Group Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 31.59
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SMGZY, the sentiment is Positive. The current price of 31.59 is above the 20-day moving average (MA) of 30.61, above the 50-day MA of 29.45, and above the 200-day MA of 24.57, indicating a bullish trend. The MACD of 0.51 indicates Positive momentum. The RSI at 69.17 is Neutral, neither overbought nor oversold. The STOCH value of 83.91 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SMGZY.

Smiths Group Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ITT	76 Outperform	$12.41B	25.33	19.27%	0.89%	6.99%	23.25%
RRX	72 Outperform	$9.66B	41.49	3.69%	0.96%	-10.19%	―
CR	72 Outperform	$10.78B	36.68	18.82%	0.49%	6.65%	39.13%
SMGZY	70 Outperform	$10.26B	27.83	14.19%	1.18%	8.47%	36.10%
AOS	69 Neutral	$9.67B	19.79	27.97%	2.00%	-1.60%	-7.12%
Sector *	65 Neutral	$10.86B	15.57	5.28%	1.92%	3.13%	-27.76%
GNRC	64 Neutral	$8.67B	25.55	14.29%	―	8.07%	58.67%